Skip to main content
NIH funding notice RFA-OD-20-020

Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed)

Closed on September 18, 2020.

Posted
August 6, 2020
Close date
September 18, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,577,546 in first-year total cost, median $817,335.

Most frequent study sections

  1. ZDE1-SRC(99)3

Most frequent institutions

  1. ATOM BIOWORKS INC1
  2. MPOD, INC.1
  3. QUICKSILVER BIOSCIENCES, INC.1
Competing awards under RFA-OD-20-020 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Designer DNA Nanostructure Based Biosensing for Rapid COVID19 Detection and Monitoring using Saliva Sample1R44DE030852-01YAO, XIAOHUATOM BIOWORKS INC, NC$1,257,963ZDE1
2021Direct bioelectronic detection of SARS-CoV-2 from saliva using single-molecule field-effect transistor array1R44DE030841-01SHEPARD, KENNETH LYOUNG, ERIK F.QUICKSILVER BIOSCIENCES, INC., NY$817,335ZDE1
2021A scalable aptamer-based electrochemical biosensor for rapid detection of SARS-CoV-2 from saliva1R44DE030842-01LY, JEFFREYMPOD, INC., MD$502,248ZDE1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.